Clinical effect of nifedipine and irbesartan in the treatment of diabetes and hypertension
Kai Li
Abstract
Kai Li
Abstract
Objective To investigate the clinical effect of nifedipine and irbesartan in the treatment of diabetes and hypertension. Methods Retrospectively analyzed the clinical data of 64 cases of diabetes and hypertension patients who were admitted to our hospital from July, 2010 to July,2012. Results The effective rate of the observation group was 90.6%,and the control group 75% the difference was statistically significant(P0.05).And compared to the control group, the observation group patients'blood pressure fell more obvious after treatment,the difference was statistically significant (P0.05). Conclusion Nifedipine and irbesartan have a good therapeutic effect in the treatment of diabetes and hypertension and it deserves to be widely promoted in the clinical.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical effect of nifedipine and irbesartan in the treatment of diabetes and hypertension. Methods Retrospectively analyzed the clinical data of 64 cases of diabetes and hypertension patients who were admitted to our hospital from July, 2010 to July,2012. Results The effective rate of the observation group was 90.6%,and the control group 75% the difference was statistically significant(P0.05).And compared to the control group, the observation group patients'blood pressure fell more obvious after treatment,the difference was statistically significant (P0.05). Conclusion Nifedipine and irbesartan have a good therapeutic effect in the treatment of diabetes and hypertension and it deserves to be widely promoted in the clinical.
Key concepts: Medicine, Irbesartan, Nifedipine, Diabetes mellitus, Blood pressure, Significant difference, Internal medicine, Endocrinology